- Home
- ARVN vs CMCO Comparison
ARVN vs CMCO Comparison
Compare ARVN & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CMCO
- Stock Information
- Founded
- ARVN 2015
- CMCO 1875
- Country
- ARVN United States
- CMCO United States
- Employees
- ARVN N/A
- CMCO N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CMCO Construction/Ag Equipment/Trucks
- Sector
- ARVN Health Care
- CMCO Industrials
- Exchange
- ARVN Nasdaq
- CMCO Nasdaq
- Market Cap
- ARVN 456.2M
- CMCO 446.1M
- IPO Year
- ARVN 2018
- CMCO 1996
- Fundamental
- Price
- ARVN $7.81
- CMCO $15.85
- Analyst Decision
- ARVN Buy
- CMCO Hold
- Analyst Count
- ARVN 21
- CMCO 1
- Target Price
- ARVN $20.53
- CMCO $35.00
- AVG Volume (30 Days)
- ARVN 1.8M
- CMCO 336.7K
- Earning Date
- ARVN 07-29-2025
- CMCO 07-30-2025
- Dividend Yield
- ARVN N/A
- CMCO 1.75%
- EPS Growth
- ARVN N/A
- CMCO N/A
- EPS
- ARVN N/A
- CMCO N/A
- Revenue
- ARVN $426,900,000.00
- CMCO $963,027,000.00
- Revenue This Year
- ARVN $7.57
- CMCO $10.17
- Revenue Next Year
- ARVN N/A
- CMCO $33.08
- P/E Ratio
- ARVN N/A
- CMCO N/A
- Revenue Growth
- ARVN 498.74
- CMCO N/A
- 52 Week Low
- ARVN $5.90
- CMCO $11.78
- 52 Week High
- ARVN $34.11
- CMCO $41.05
- Technical
- Relative Strength Index (RSI)
- ARVN 54.65
- CMCO 59.03
- Support Level
- ARVN $7.58
- CMCO $15.55
- Resistance Level
- ARVN $8.31
- CMCO $16.62
- Average True Range (ATR)
- ARVN 0.39
- CMCO 0.64
- MACD
- ARVN 0.03
- CMCO 0.18
- Stochastic Oscillator
- ARVN 64.75
- CMCO 90.05
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CMCO Columbus McKinnon Corporation
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.